摘要
胞外-5’-核苷酸酶(ecto-5’-NT、 5’-NT、 eN、 CD73)是一种膜酶,其主要由AMP腺苷的胞外产物构成。Ecto-5''-NT是由多种类型的癌症细胞过表达,导致了肿瘤微环境腺苷浓度的提高。发现腺苷在癌症机理中也很重要,对抗肿瘤T细胞和巨噬细胞表现出较强的免疫抑制作用,促进心血管生成和细胞粘附。这些作用帮助细胞生长与发展。提示ecto-5’-NT的抑制导致肿瘤微环境中胞外腺苷浓度的降低,这将直接影响肿瘤细胞并致使肿瘤恶性细胞易受宿主防御系统的影响。此机制被提议为癌症治疗的有希望的新靶点。本综述的目的是为了探索ecto-5’-NT生化和结构特征,包括分子模拟活性部位的简要分析,分子模拟是评估这种酶的抑制是否能够确实代表治疗癌症的可行性策略的一种方法。对在癌症治疗期间可能被用作ecto-5’-NT靶点的已知抑制剂和可能的原型也进行了讨论。
关键词: 腺苷,癌症治疗,胞外-5’-核苷酸酶,酶抑制,新靶点,嘌呤信号。
Current Medicinal Chemistry
Title:Insights into Ecto-5’-Nucleotidase as a New Target for Cancer Therapy: A Medicinal Chemistry Study
Volume: 22 Issue: 15
Author(s): Patricia Frasson Corbelini, Fabricio Figueiro, Gustavo Machado das Neves, Saulo Andrade and Daniel Fabio Kawano, Ana Maria Oliveira Battastini and Vera Lucia Eifler-Lima
Affiliation:
关键词: 腺苷,癌症治疗,胞外-5’-核苷酸酶,酶抑制,新靶点,嘌呤信号。
摘要: Ecto-5’-nucleotidase (ecto-5’-NT, 5’-NT, eN, CD73) is a membrane ectoenzyme that is primarily responsible for the extracellular production of adenosine from AMP. Ecto-5'-NT is overexpressed in various types of cancer cells, leading to elevated concentrations of adenosine in the tumour microenvironment. Adenosine has also been found to be important in cancer pathogenesis, showing strong immunosuppressive effects over antitumour T cells and macrophages and promoting neovascularization and cell adherence. These actions support tumour growth and development. It has been suggested that the inhibition of ecto-5’-NT results in lower extracellular concentrations of adenosine within the tumour microenvironment, which would directly affect cancer cells and render malignant cells more susceptible to host defence systems. Such mechanisms are proposed to represent promising new targets for cancer therapy. The aim of this review is to explore the biochemical and structural features of ecto-5’-NT, including a brief analysis of its active site by molecular modelling, as a means of evaluating whether the inhibition of this enzyme does indeed represent a feasible strategy for treating cancer. Known inhibitors and possible prototypes that could be used to target ecto-5’-NT during cancer therapy are also discussed.
Export Options
About this article
Cite this article as:
Patricia Frasson Corbelini, Fabricio Figueiro, Gustavo Machado das Neves, Saulo Andrade and Daniel Fabio Kawano, Ana Maria Oliveira Battastini and Vera Lucia Eifler-Lima , Insights into Ecto-5’-Nucleotidase as a New Target for Cancer Therapy: A Medicinal Chemistry Study, Current Medicinal Chemistry 2015; 22 (15) . https://dx.doi.org/10.2174/0929867322666150408112615
DOI https://dx.doi.org/10.2174/0929867322666150408112615 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Infection, Infectious Agents and Vascular Disease
Reviews on Recent Clinical Trials Aflibercept (VEGF-TRAP): The Next Anti-VEGF Drug
Inflammation & Allergy - Drug Targets (Discontinued) Ricin and Saporin: Plant Enzymes for the Research and the Clinics
Current Chemical Biology Ectopic Thyroid Gland: Description of a Case and Review of the Literature
Endocrine, Metabolic & Immune Disorders - Drug Targets The cytotoxic effect of GW843682X on nasopharyngeal carcinoma
Anti-Cancer Agents in Medicinal Chemistry Endometriosis and Perinatal Outcome - A Systematic Review of the Literature
Current Women`s Health Reviews Fiber Optic Sensors for Biomedical Applications
Current Analytical Chemistry The Paths to Neurodegeneration in Genetic Parkinson's Disease
CNS & Neurological Disorders - Drug Targets B Cell Modulation Strategies in Autoimmunity: The SLE Example
Current Pharmaceutical Design Targeting Proliferating Cell Nuclear Antigen (PCNA) as an Effective Strategy to Inhibit Tumor Cell Proliferation
Current Cancer Drug Targets Estrogen Receptor Beta in Cancer: an Attractive Target for Therapy
Current Pharmaceutical Design Glutamate Carboxypeptidase II in Diagnosis and Treatment of Neurologic Disorders and Prostate Cancer
Current Medicinal Chemistry Patent Selections
Recent Patents on Biotechnology Interaction Between Retinoids and Eicosanoids: Their Relevance to Cancer Chemoprevention
Current Nutrition & Food Science Scintigraphic Imaging of Inflammatory Processes
Medicinal Chemistry Reviews - Online (Discontinued) Vascular Endothelial Growth Factor as an Anti-Angiogenic Target for Cancer Therapy
Current Drug Targets Molecular Evidence of Cryptotanshinone for Treatment and Prevention of Human Cancer
Anti-Cancer Agents in Medicinal Chemistry The Wnt/Beta-Catenin Pathway in Wilms Tumors and Prostate Cancers
Current Molecular Medicine Role of Mitochondrial Heat-shock Proteins and Immunophilins in Neuro Degenerative Diseases
Current Drug Targets Circulating Tumor Stem Cells as Biomarkers for Cancer Progression
Recent Patents on Biomarkers